spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Apotex 

 HSMN NewsFeed - 16 Jul 2018
Aurobindo Signs a Definitive Agreement to Acquire Apotex' Businesses in Poland, Czech Republic, the Netherlands, Spain and Belgium
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 23 Mar 2018
Lannett Strengthens, Augments Management Team
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 8 Dec 2016
Vanda Pharmaceuticals Settles Fanapt(R) Patent Litigation with Apotex
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 14 Jun 2016
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
Biopharmaceuticals Generics Drug Delivery Product Launch
 HSMN NewsFeed - 22 Mar 2016
Apotex Launches First Generic Version of Merck's Nasonex(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 10 Sep 2014
Mylan to Acquire U.S. Rights to Arixtra(R) (fondaparinux sodium) Injection from Aspen
Biopharmaceuticals Generics
 HSMN NewsFeed - 24 Sep 2013
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Mar 2013
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex(R) (celecoxib capsules)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Sep 2011
ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox(R) (deferiprone) Approval
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Mar 2008
Cangene's anti-hepatitis B product granted orphan-drug exclusive approval by the U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jan 2008
Pfizer to Appeal Canadian Federal Court Ruling on Lipitor Patent; Court's Decision Will Have No Immediate Commercial Impact
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Dec 2007
Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
Biopharmaceuticals
 HSMN NewsFeed - 19 Nov 2007
Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve BP Goals
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 19 Jun 2007
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Jun 2007
U.S. Department of Justice Investigation of Bristol-Myers Squibb in Proposed Plavix Patent Settlement Is Resolved
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 30 May 2007
Bristol-Myers Squibb Pleads Guilty to Lying to the Federal Government About Deal Involving Blood-Thinning Drug
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 May 2007
Bristol-Myers Squibb Announces Agreement in Principle to Resolve Federal Antitrust Investigation
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2007
Synovics Pharmaceuticals Appoints David Coffin-Beach President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Apr 2007
U.S. Federal Circuit Court Affirms Judgment for Allergan, Inc. and Roche Palo Alto, LLC against Apotex, Inc., Apotex Corp., and Novex Pharma in Ketorolac Patent Infringement Lawsuit
Biopharmaceuticals Ophthalmology Generics Litigation
 HSMN NewsFeed - 9 Apr 2007
FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Apr 2007
FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Mar 2007
Pfizer Statement in Response to Appeals Court Decision in Norvasc Patent Case
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Mar 2007
Cangene receives an approvable letter from the FDA for human growth hormone
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Feb 2007
Pfizer Wins Challenge to Norvasc Patent by Mylan
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 27 Dec 2006
Dr. Reddy's Announces Final Approval of Ondansetron Tablets with 180-Days of Marketing Exclusivity
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Sep 2006
Plavix(R) Preliminary Injunction Appeal
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Sep 2006
Bristol-Myers Squibb Board of Directors Announces Departure of Peter R. Dolan as CEO and Appointment of James M. Cornelius as Interim CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2006
New Clinical Data Show Enoxaparin Significantly Reduces the Risk of Repeat Heart Attacks and Stroke in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2006
Pfizer Wins Norvasc Patent Challenge by Generic Manufacturer Synthon
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Aug 2006
Motion Filed for Preliminary Injunction in PLAVIX(R) Patent Infringement Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 28 Jul 2006
PLAVIX(R) Litigation Settlement Fails to Receive Antitrust Clearance From States Attorneys General
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 5 Jun 2006
Allergan Wins ACULAR(R) Patent Infringement Lawsuit Against Apotex, Inc., Apotex Corp., and Novex Pharma
Biopharmaceuticals Ophthalmology Generics Litigation
 HSMN NewsFeed - 25 Apr 2006
Teva Receives First FDA Approval for Generic Pravachol(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Apr 2006
Teva Provides Update on Generic Pravachol(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Apr 2006
Teva Announces Stay of Approval for Generic Pravachol Lifted
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Apr 2006
District Court Denies Apotex's Request to Block Teva's Introduction of First Generic Pravachol(R) In The U.S.
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 12 Apr 2006
Teva Announces FDA Determination That Generic Pravachol Exclusivity Has Not Been Triggered
Biopharmaceuticals Generics
 HSMN NewsFeed - 22 Mar 2006
Apotex Announces Agreement to Settle U.S. PLAVIX(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 21 Mar 2006
Sanofi-aventis and Bristol-Myers Squibb Announce Agreement to Settle U.S. PLAVIX(R) Litigation with Apotex Subject to Certain Conditions
Biopharmaceuticals Litigation
 HSMN NewsFeed - 18 Jan 2006
Pfizer Wins Norvasc Patent Challenge by Generic Manufacturer Apotex
Biopharmaceuticals Generics Cardiology Litigation
 HSMN NewsFeed - 3 Jan 2006
Allergan Granted Temporary Restraining Order in ACULAR(R) Patent Infringement Case
Biopharmaceuticals Ophthalmology Generics Litigation
Return to NewsFeed  

 Additional items found! 30

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 30 additional stories matching:
Apotex
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.